Bridging the gap: Insights in the immunopathology of Lyme borreliosis
European Journal of Immunology · 2024
DOI: 10.1002/eji.202451063 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Marijn E Snik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Lyme Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Lyme borreliosis (LB), caused by Borrelia burgdorferi sensu lato (Bbsl) genospecies transmitted by Ixodes spp. ticks, is a significant public health concern in the Northern Hemisphere. This review highlights the complex interplay between Bbsl infection and host–immune responses, impacting clinical manifestations and long‐term immunity. Early localized disease is characterized by erythema migrans (EM), driven by T‐helper 1 (Th1) responses and proinflammatory cytokines. Dissemination to the heart and CNS can lead to Lyme carditis and neuroborreliosis respectively, orchestrated by immune cell infiltration and chemokine dysregulation. More chronic manifestations, including acrodermatitis chronica atrophicans and Lyme arthritis, involve prolonged inflammation as well as the development of autoimmunity. In addition, dysregulated immune responses impair long‐term immunity, with compromised B‐cell memory and antibody responses. Experimental models and clinical studies underscore the role of Th1/Th2 balance, B‐cell dysfunction, and autoimmunity in LB pathogenesis. Moreover, LB‐associated autoimmunity parallels mechanisms observed in other infectious and autoimmune diseases. Understanding immune dysregulation in LB provides insights into disease heterogeneity and could provide new strategies for diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, the Netherlands.
- Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC Multidisciplinary Lyme borreliosis Center, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
ORCID-Profile: Melissa M J van Gool
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Snik, M. E., Stouthamer, N. E. I. M., Hovius, J. W., & van Gool, M. M. J. (2024). Bridging the gap: Insights in the immunopathology of Lyme borreliosis. European Journal of Immunology. https://doi.org/10.1002/eji.202451063
Vancouver
Snik ME, Stouthamer NEIM, Hovius JW, van Gool MMJ. Bridging the gap: Insights in the immunopathology of Lyme borreliosis. European Journal of Immunology. 2024. doi:10.1002/eji.202451063
BibTeX
@article{Snik2024,
author = {Snik, Marijn E and Stouthamer, Noor E I M and Hovius, Joppe W and van Gool, Melissa M J},
title = {Bridging the gap: Insights in the immunopathology of Lyme borreliosis},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202451063}
}
EUVIMED